Wellbiotec Co., Ltd.

KRX:010600.KS

545 (KRW) • At close April 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -64,910.322-6,418.575-19,631.866-67,825.461-16,552.641-16,307.43-8,743.063-2,457.077555.743-6,734.5542,406.562-2,939.1081,703.984-12,846.928-10,708.758-27,664.399-6,424.073
Depreciation & Amortization 1,473.1531,360.8582,284.682,877.6992,745.6661,387.3618.55565.096693.6221,026.9891,775.5072,186.3013,077.4713,450.2747,281.2275,590.6042,756.028
Deferred Income Tax -3,185.872015,782.0959,534.1585,441.3754,466.91300000000000
Stock Based Compensation 584.842443.839309.8091,229.5051,370.061000000000000
Change In Working Capital 3,286.776-1,474.61-1,300.999-4,147.886-2,240.559-2,129.7891,981.895-814.0522,745.259-2,349.029-4,947.486393.074-7,697.7685,410.287-5,200.0098,829.028-339.845
Accounts Receivables 2,564.3281,227.404-13,273.19-6,103.275-2,335.815000000000000
Inventory -600.274736.435744.639-134.713431.8724,504.841358.71-2,041.7354,210.221926.158-786.1291,739.06-8,821.941-248.3687,181.471-8,376.384-1,265.423
Accounts Payables -1,618.7782,048.4019,152.5881,639.89886.409000000000000
Other Working Capital 2,941.5-5,486.8492,074.964450.204-423.025-6,634.631,623.1851,227.683-1,464.962-3,275.187-4,161.357-1,345.9861,124.1735,658.655-12,381.4817,205.412925.578
Other Non Cash Items 58,583.2828,711.9023,269.2562,627.1721,508.6122,941.5622,124.491340.442282.8526,522.2361,775.623,418.632,670.3086,889.8626,583.06916,354.0923,116.2
Operating Cash Flow -4,168.142,623.414712.97-5,704.813-7,727.487-9,274.913-4,018.127-2,365.5914,277.476-1,534.3581,010.2033,058.897-246.0052,903.495-2,044.4713,109.325-891.69
Investing Activities:
Investments In Property Plant And Equipment -1,082.713-508.762-762.58-1,275.931-6,100.104-1,441.423-4,891.389-1,975.575-952.036-9,695.357-285.308-826.928-4,202.632-440.668-122.883-9,343.862-7,362.054
Acquisitions Net 54.29220,550.4116,739.523-6.304-428.702-16,793.006-17,240.105000311.273185.4-2,113.133-12,304.03-3.9-1,035.00211,731.996
Purchases Of Investments -34,060-21,199.999-13,805.33-20,727.473-31,136.349-28,365.802-2,123000-866.056-250.033-85.939-2,997.718-4,767-48,988.34-40,623.842
Sales Maturities Of Investments 14,00017,130.9615,325.6398,631.71429,122.615,187.532-3,173.842001,069.589954.2261252,4101,6709,846.17949,911.02826,238.113
Other Investing Activites -1,540.985-84.987445.121-13,580.72246.86815,660.7523,343.50262.927-35.275-683.79179.944-02,158.106-130.8896,848.445907.9242,407.057
Investing Cash Flow -22,629.40615,887.6247,942.374-26,958.714-8,295.687-15,751.947-24,084.834-1,912.648-987.311-9,309.559194.08-766.561-1,833.598-14,203.30511,800.841-8,548.252-7,608.73
Financing Activities:
Debt Repayment -19,339.5-26,531.284-25,740.447-6,231.84-12,888.097-17,145.438-2,309.1480-2,065.6580-6,039.792-2,459.908-1,983.108-7,309.802-27,494.402-60,643.564-86,033.707
Common Stock Issued 7,944.304-30.061-79.734-13.7584,434.41534,599.981000997.2271,946.081288.681017,907.2192,985.43324,894.5761,976.507
Common Stock Repurchased 000000000000-0.66700-0.3720
Dividends Paid 000000000000000-46,732.9820
Other Financing Activities -54.69614,773.01239,520.99130,026.51416,591.33917,622.74434,489.9523,125.339710.9198,959.571,761.76404,021.1251,061.8039,613.40793,465.96593,431.34
Financing Cash Flow 26,478.873-11,788.33213,700.8123,780.9168,137.65835,077.28832,180.8043,125.339-1,354.7399,956.797-2,331.947-2,171.2272,037.3511,659.22-14,895.56210,983.6239,374.14
Other Information:
Effect Of Forex Changes On Cash -10.383-218.47793.446-27.58948.629-2.208216.775-49.34166.518342.19554.211-408.685721.57-0.001-12.3740-1,277.566
Net Change In Cash -329.0576,504.2292,161.178-8,910.2-7,836.8889,986.5635,430.28-1,202.2412,001.945-544.926-1,073.452-287.576679.317359.409-5,151.5665,544.696-403.846
Cash At End Of Period 10,084.46110,413.5183,909.2891,748.11110,658.31118,495.1998,508.6363,078.3564,280.5972,278.6532,823.5793,897.0314,184.6072,458.9882,099.5797,251.1451,706.449